EyeCyte Company
EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
La Jolla, California, United States
Founded Date:
2005
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
1
Total Funding:
$3M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership